Inflammation, Attention, and Processing Speed in Patients With Breast Cancer Before and After Chemotherapy

被引:17
作者
Belcher, Elizabeth K. [1 ]
Culakova, Eva [1 ]
Gilmore, Nikesha J. [1 ]
Hardy, Sara J. [1 ,2 ]
Kleckner, Amber S. [1 ]
Kleckner, Ian R. [1 ]
Lei, Lianlian [3 ]
Heckler, Charles [1 ]
Sohn, Michael B. [4 ]
Thompson, Bryan D. [1 ]
Lotta, Louis T. [1 ]
Werner, Zachary A. [1 ]
Geer, Jodi [5 ]
Hopkins, Judith O. [6 ]
Corso, Steven W. [7 ]
Rich, David Q. [8 ]
van Wijngaarden, Edwin [8 ]
Janelsins, Michelle C. [1 ]
机构
[1] Univ Rochester, Dept Surg, Support Care Canc Div, Med Ctr, 265 Crittenden Blvd,Box 658, Rochester, NY 14642 USA
[2] Univ Rochester, Dept Radiat Oncol, Med Ctr, Rochester, NY 14642 USA
[3] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA
[4] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14642 USA
[5] Metro Minnesota Community Oncol Res Consortium, Louis Park, MN USA
[6] Novant Hlth Canc Inst, Kernersville, NC USA
[7] Spartanburg Reg Med Ctr, Community Oncol Res Program, Upstate Carolina Natl Canc Inst, Spartanburg, SC USA
[8] Univ Rochester, Dept Publ Hlth Sci, Med Ctr, Rochester, NY 14642 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2022年 / 114卷 / 05期
关键词
TUMOR-NECROSIS-FACTOR; COGNITIVE IMPAIRMENT; TNF-ALPHA; PERIPHERAL INFLAMMATION; WORKING-MEMORY; SERUM-LEVELS; MECHANISMS; CYTOKINES; PERFORMANCE; MARKERS;
D O I
10.1093/jnci/djac022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Inflammation may contribute to cognitive difficulties in patients with breast cancer. We tested 2 hypotheses: inflammation is elevated in patients with breast cancer vs noncancer control participants and inflammation in patients is associated with worse attention and processing speed over the course of chemotherapy. Methods Serum cytokines (interleukin [IL]-4, 6, 8, 10; tumor necrosis factor [TNF]-alpha) and soluble receptors [sTNFRI, II]) were measured in 519 females with breast cancer before and after chemotherapy and 338 females without cancer serving as control participants. Attention and processing speed were measured by Rapid Visual Processing (RVP), Backward Counting (BCT), and Trail Making-A (TMT-A) tests. Linear regression models examined patient vs control cytokines and receptor levels, adjusting for covariates. Linear regression models also examined relationships between patient cytokines and receptor levels and test performance, adjusting for age, body mass index, anxiety, depression, cognitive reserve, and chemotherapy duration. Statistical tests were 2-sided (alpha = .05). Results sTNFRI and sTNFRII increased over time in patients relative to controls, whereas IL-4, IL-6, and IL-10 decreased. Prechemotherapy, higher IL-8 associated with worse BCT (beta = 0.610, SE = 0.241, P = .01); higher IL-4 (beta = -1.098, SE = 0.516, P = .03) and IL-10 (beta = -0.835, SE = 0.414, P = .04) associated with better TMT-A. Postchemotherapy, higher IL-8 (beta = 0.841, SE = 0.260, P = .001), sTNFRI (beta = 6.638, SE = 2.208, P = .003), and sTNFRII (beta = 0.913, SE = 0.455, P = .045) associated with worse BCT; higher sTNFRII also associated with worse RVP (beta = -1.316, SE = 0.587, P = .03). At prechemotherapy, higher IL-4 predicted RVP improvement over time (beta = 0.820, SE = 0.336, P = .02); higher sTNFRI predicted worse BCT over time (beta = 5.566, SE = 2.367, P = .02). Longitudinally, increases in IL-4 associated with BCT improvement (beta = -0.564, SE = 0.253, P = .03). Conclusions Generally, worse attention and processing speed were associated with higher inflammatory cytokines and receptors and lower anti-inflammatory cytokines in patients; future confirmatory studies are needed.
引用
收藏
页码:712 / 721
页数:10
相关论文
共 85 条
[41]   Inflammation as a treatment target in mood disorders: review [J].
Jones, Brett D. M. ;
Daskalakis, Zafiris J. ;
Carvalho, Andre F. ;
Strawbridge, Rebecca ;
Young, Allan H. ;
Mulsant, Benoit H. ;
Husain, M. Ishrat .
BJPSYCH OPEN, 2020, 6 (04)
[42]   Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors [J].
Kesler, Shelli ;
Janelsins, Michelle ;
Koovakkattu, Della ;
Palesh, Oxana ;
Mustian, Karen ;
Morrow, Gary ;
Dhabhar, Firdaus S. .
BRAIN BEHAVIOR AND IMMUNITY, 2013, 30 :S109-S116
[43]   Monitoring Cognitive Functioning: Psychometric Properties of the Brief Test of Adult Cognition by Telephone [J].
Lachman, Margie E. ;
Agrigoroaei, Stefan ;
Tun, Patricia A. ;
Weaver, Suzanne L. .
ASSESSMENT, 2014, 21 (04) :404-417
[44]   Mechanisms of Neurotoxic Symptoms as a Result of Breast Cancer and Its Treatment: Considerations on the Contribution of Stress, Inflammation, and Cellular Bioenergetics [J].
Lacourt T.E. ;
Heijnen C.J. .
Current Breast Cancer Reports, 2017, 9 (2) :70-81
[45]   Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors [J].
Lange, M. ;
Joly, F. ;
Vardy, J. ;
Ahles, T. ;
Dubois, M. ;
Tron, L. ;
Winocur, G. ;
De Ruiter, M. B. ;
Castel, H. .
ANNALS OF ONCOLOGY, 2019, 30 (12) :1925-1940
[46]  
Lim A, 2013, MOD TR PHARMACOPSYCH, V28, P175, DOI 10.1159/000346362
[47]   The Trail Making Test: Association With Other Neuropsychological Measures and Normative Values for Adults Aged 55 Years and Older From a Spanish-Speaking Population-Based Sample [J].
Llinas-Regla, Jordi ;
Vilalta-Franch, Joan ;
Lopez-Pousa, Secundino ;
Calvo-Perxas, Laia ;
Torrents Rodas, David ;
Garre-Olmo, Josep .
ASSESSMENT, 2017, 24 (02) :183-196
[48]   Revisiting the Mechanisms of CNS Immune Privilege [J].
Louyeau, Antoine ;
Harris, Tajie H. ;
Kipnis, Jonathan .
TRENDS IN IMMUNOLOGY, 2015, 36 (10) :569-577
[49]   Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer [J].
Lyon, Debra E. ;
Cohen, Ronald ;
Chen, Huaihou ;
Kelly, Debra L. ;
McCain, Nancy L. ;
Starkweather, Angela ;
Ahn, Hyochol ;
Sturgill, Jamie ;
Jackson-Cook, Colleen K. .
JOURNAL OF NEUROIMMUNOLOGY, 2016, 301 :74-82
[50]   IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients [J].
Ma, Yunfeng ;
Ren, Yi ;
Dai, Zhi-Jun ;
Wu, Cai-Jun ;
Ji, Yan-Hong ;
Xu, Jiru .
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (03) :421-426